Patients colonized with vancomycin-resistant enterococci (VRE)—particularly immunocompromised patients—are at increased risk of developing subsequent VRE infections. Repeated antibiotic therapies are not an option for decolonization in patients receiving immunosuppressive therapy, as antibiotic-induced selection pressure may promote the further spread of multidrug-resistant enterococci. Effective and sustainable strategies for reducing or eradicating [...]